LivaNova PLC (NASDAQ:LIVN) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. lessened its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 19.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 171,402 shares of the company’s stock after selling 41,335 shares during the quarter. Principal Financial Group Inc. owned approximately 0.32% of LivaNova worth $9,005,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Emerald Advisers LLC boosted its position in LivaNova by 2.1% during the third quarter. Emerald Advisers LLC now owns 695,505 shares of the company’s stock worth $36,542,000 after acquiring an additional 14,302 shares during the last quarter. abrdn plc grew its position in shares of LivaNova by 43.8% in the third quarter. abrdn plc now owns 232,025 shares of the company’s stock valued at $12,191,000 after purchasing an additional 70,618 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in shares of LivaNova by 7.3% in the third quarter. State of Alaska Department of Revenue now owns 6,246 shares of the company’s stock valued at $328,000 after purchasing an additional 425 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in LivaNova by 3.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 797,284 shares of the company’s stock worth $41,889,000 after buying an additional 25,277 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management UK Ltd. boosted its stake in LivaNova by 11.8% during the third quarter. Mitsubishi UFJ Asset Management UK Ltd. now owns 19,000 shares of the company’s stock worth $998,000 after buying an additional 2,000 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

LivaNova Trading Up 0.8 %

Shares of NASDAQ LIVN opened at $52.53 on Tuesday. The stock has a fifty day simple moving average of $51.77 and a 200-day simple moving average of $52.86. LivaNova PLC has a twelve month low of $42.75 and a twelve month high of $64.47. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $2.85 billion, a PE ratio of 125.05 and a beta of 1.01.

Analyst Ratings Changes

Several research analysts have recently commented on the company. StockNews.com lowered LivaNova from a “strong-buy” rating to a “buy” rating in a report on Saturday. Stifel Nicolaus boosted their target price on shares of LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, July 25th. The Goldman Sachs Group started coverage on shares of LivaNova in a research report on Friday, October 4th. They set a “buy” rating and a $65.00 price target on the stock. Baird R W upgraded LivaNova from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 17th. Finally, Mizuho reduced their target price on LivaNova from $80.00 to $70.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $69.17.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.